title: Infantile hemangiomas of the head and neck.
abstract: Infantile hemangiomas (IHs) are benign vascular tumors. Clinical history and physical examination are the most important factors for diagnosis, with most IHs having a typical presentation. Treatment is required for some IHs that cause significant cosmetic deformity or functional compromise. Propranolol is the first-line treatment of most IHs. Ongoing research is increasing our understanding of the pathophysiology of these tumors and should help to identify future potential therapeutic targets.
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA.
authors.forename: Kevin C
authors.initials: KC
authors.lastname: Huoh
authors.forename: Kristina W
authors.initials: KW
authors.lastname: Rosbe
mesh_terms: D003952:Diagnostic Imaging; D006258:Head and Neck Neoplasms / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D006391:Hemangioma / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007223:Infant; D011433:Propranolol / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D014665:Vasodilator Agents; D011433:Propranolol
keywords: Glucose transporter 1 (GLUT 1); Head and neck; PHACES; Pediatric hemangioma; Propranolol; Subglottic hemangioma